During your consultation, well provide transparent pricing so you know exactly what to budget
Wang D, Luo P, Wang Y, Li W, Wang C, Sun D, Zhang R, Su T, Ma X, Zeng C, Wang H, Ren J, Cao F: Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism
CT-388 (enicepatide), a dual GLP-1/GIP injectable, delivered 22.5% weight loss in Phase 2 with 54% of patients on the highest dose achieving a BMI under 30
In this trial, CSF samples were taken, showing that the drug was able to cross the BBB and that 12 weeks after the trial had stopped, there was no drug present in the CSF anymore
What PlexusDx Patients Should Know About Safety Screening Before starting any GLP-1 medication from PlexusDx, baseline kidney function assessment is standard medical practice
The goal is to build habits they can sustain long term